Sangamo BioSciences Inc (SGMO.OQ)
SGMO.OQ on NASDAQ Stock Exchange Global Market
5.72USD
22 Oct 2012
5.72USD
22 Oct 2012
Price Change (% chg)
$-0.05 (-0.87%)
$-0.05 (-0.87%)
Prev Close
$5.77
$5.77
Open
$5.76
$5.76
Day's High
$5.81
$5.81
Day's Low
$5.70
$5.70
Volume
6,097
6,097
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins. ZFPs can be engineered to make ZFP nucleases (ZFNs), proteins that can be... (more)
Overall
Beta: | 1.60 |
Market Cap (Mil.): | $304.34 |
Shares Outstanding (Mil.): | 52.75 |
Dividend: | -- |
Yield (%): | -- |
Financials
SGMO.OQ | Industry | Sector | |
---|---|---|---|
P/E (TTM): | -- | 29.84 | 28.43 |
EPS (TTM): | -0.55 | -- | -- |
ROI: | -33.66 | 4.18 | 4.21 |
ROE: | -35.73 | 4.88 | 4.35 |
Competitors
Price | Change | |
---|---|---|
Eli Lilly & Co. (LLY.N) | $52.64 | -0.22 |
Merck & Co., Inc. (MRK.N) | $46.50 | -0.53 |
Pfizer Inc. (PFE.N) | $25.57 | -0.19 |
Exelixis, Inc. (EXEL.OQ) | $4.63 | -0.09 |
Takeda Pharmaceutical Company Limited (4502.T) | ¥3,680 | +10.00 |
Amgen, Inc. (AMGN.OQ) | $88.47 | +1.31 |
Biogen Idec Inc. (BIIB.OQ) | $145.17 | -0.48 |
Biogen Idec Inc. (68246039) | -- | -- |
Johnson & Johnson (JNJ.N) | $71.87 | +0.01 |
GenVec, Inc. (GNVC.OQ) | $1.60 | +0.04 |
Earnings vs. Estimates
Analyst Research Reports
Report Title | Price |
---|---|
Provider: Pechala's Reports
|
$25.00
|
Provider: Standard & Poor's Quantitative Report
|
$58.00
|
Provider: Pechala's Reports
|
$10.00
|
Provider: Reuters Investment Profile
|
$20.00
|
Provider: New Constructs, LLC
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.